- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Nausea and vomiting
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Aprepitant – July 2019
Aprepitant: Capsule 165 mg; Apotex® Aprepitant
Last updated
9 July 2025